-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
What Type Of Shareholders Own The Most Number of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Shares?
What Type Of Shareholders Own The Most Number of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Shares?
A look at the shareholders of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Warren Buffett said that he likes "a business with enduring competitive advantages that is run by able and owner-oriented people." So it's nice to see some insider ownership, because it may suggest that management is owner-oriented.
CK Life Sciences Int'l. (Holdings) has a market capitalization of HK$8.1b, so we would expect some institutional investors to have noticed the stock. In the chart below, we can see that institutions don't own many shares in the company. Let's take a closer look to see what the different types of shareholders can tell us about CK Life Sciences Int'l. (Holdings).
See our latest analysis for CK Life Sciences Int'l. (Holdings)
SEHK:775 Ownership Breakdown July 25th 2022What Does The Lack Of Institutional Ownership Tell Us About CK Life Sciences Int'l. (Holdings)?
Institutional investors often avoid companies that are too small, too illiquid or too risky for their tastes. But it's unusual to see larger companies without any institutional investors.
There are multiple explanations for why institutions don't own a stock. The most common is that the company is too small relative to funds under management, so the institution does not bother to look closely at the company. On the other hand, it's always possible that professional investors are avoiding a company because they don't think it's the best place for their money. CK Life Sciences Int'l. (Holdings) might not have the sort of past performance institutions are looking for, or perhaps they simply have not studied the business closely.
SEHK:775 Earnings and Revenue Growth July 25th 2022Hedge funds don't have many shares in CK Life Sciences Int'l. (Holdings). The company's largest shareholder is CK Hutchison Holdings Limited, with ownership of 45%. Ka-shing Li is the second largest shareholder owning 22% of common stock, and Triluck Assets Limited holds about 7.5% of the company stock.
A more detailed study of the shareholder registry showed us that 2 of the top shareholders have a considerable amount of ownership in the company, via their 67% stake.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
Insider Ownership Of CK Life Sciences Int'l. (Holdings)
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
Our information suggests that insiders maintain a significant holding in CK Life Sciences Int'l., (Holdings) Inc.. Insiders own HK$1.8b worth of shares in the HK$8.1b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.
General Public Ownership
The general public-- including retail investors -- own 24% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Private Company Ownership
It seems that Private Companies own 7.5%, of the CK Life Sciences Int'l. (Holdings) stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
Public Company Ownership
Public companies currently own 45% of CK Life Sciences Int'l. (Holdings) stock. We can't be certain but it is quite possible this is a strategic stake. The businesses may be similar, or work together.
Next Steps:
It's always worth thinking about the different groups who own shares in a company. But to understand CK Life Sciences Int'l. (Holdings) better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with CK Life Sciences Int'l. (Holdings) (at least 3 which are a bit concerning) , and understanding them should be part of your investment process.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
看看CK Life Science Int‘l,(Holdings)Inc.(HKG:775)的股东就能知道哪个集团最有权势。一般来说,随着公司的成长,机构会增加他们的持股。相反,随着时间的推移,内部人士往往会减少他们的持股。沃伦·巴菲特说,他喜欢“一家由有能力、以所有者为导向的人经营的、具有持久竞争优势的企业”。因此,看到一些内部人持股是件好事,因为这可能表明管理层是以所有者为导向的。
CK生命科学国际(控股)的市值为81亿港元,因此我们预计一些机构投资者已经注意到了这只股票。在下面的图表中,我们可以看到,机构在该公司拥有的股份并不多。让我们仔细看看不同类型的股东能告诉我们关于CK Life Science Int.(Holdings)的情况。
查看我们对CK生命科学国际公司的最新分析。
联交所:775所有权明细2022年7月25日缺乏机构所有权告诉了我们关于CK生命科学国际(控股)的什么?
机构投资者往往会避开那些规模太小、流动性太差或风险太高的公司,这些公司对他们的口味来说太小了。但在没有任何机构投资者的情况下,看到较大的公司并不常见。
对于机构为何不持有股票,有多种解释。最常见的是,相对于管理下的资金,该公司规模太小,因此该机构不会费心密切关注该公司。另一方面,专业投资者总是可能会避开一家公司,因为他们认为这不是他们投资的最佳地方。CK生命科学国际(控股)可能没有机构所寻找的那种过去的业绩,或者他们只是没有仔细研究过这项业务。
联交所:775盈利及收入增长2022年7月25日对冲基金在CK Life Science Int‘l.(Holdings)的股份并不多。该公司最大股东为长和控股有限公司,持股45%.理想汽车嘉诚为第二大股东,持有22%的普通股,Triluck Assets Limited持有约7.5%的公司股份。
对股东登记的更详细的研究表明,两个最大的股东通过他们67%的股份在公司拥有相当大的所有权。
研究机构持股是衡量和筛选股票预期表现的好方法。通过研究分析师的情绪,也可以达到同样的效果。目前,我们没有注意到分析师对该股的报道,因此该公司不太可能被广泛持有。
CK生命科学国际(控股)的内部人士所有权
不同国家对内部人的定义可能略有不同,但董事会成员总是算数的。公司管理层对董事会负责,董事会应代表股东的利益。值得注意的是,有时最高层管理人员本身也是董事会成员。
大多数人认为内部人持股是积极的,因为它可以表明董事会与其他股东很好地结盟。然而,在某些情况下,太多的权力集中在这个群体中。
我们的信息显示,内部人士持有CK生命科学国际(控股)有限公司的大量股份。在这家市值81亿港元的公司,内部人士持有价值18亿港元的股票。这是很有意义的。大多数人会说,这表明与股东的关系很好,特别是在这样一家规模如此大的公司。你可以点击这里,看看这些内部人士是一直在买入还是卖出。
一般公有制
包括散户投资者在内的普通公众持有该公司24%的股份,因此不能轻易忽视。尽管这种规模的所有权可能不足以影响有利于他们的政策决定,但他们仍然可以对公司政策产生集体影响。
私营公司所有权
看起来私营公司持有CK生命科学国际(控股)公司7.5%的股份。或许有必要对此进行更深入的研究。如果关联方,如内部人士,对这些私营公司中的一家有利害关系,则应在年报中披露。私营公司也可能对该公司拥有战略利益。
上市公司所有权
上市公司目前持有CK生命科学国际(控股)公司45%的股份。我们不能确定,但很有可能这是一个战略利益攸关方。这些业务可能是相似的,也可能是合作的。
接下来的步骤:
拥有一家公司股票的不同集团总是值得考虑的。但为了更好地了解CK生命科学国际(控股),我们需要考虑许多其他因素。例如,考虑一下无处不在的投资风险幽灵。我们已经确定了4个警告信号与CK Life Science Int‘l(Holdings)(至少有3家有些担心)合作,了解它们应该是你投资过程的一部分。
当然了,如果你把目光投向别处,你可能会发现这是一笔很棒的投资。所以让我们来看看这个免费有趣的公司名单。
注:本文中的数字是使用过去12个月的数据计算的,指的是截至财务报表日期的最后一个月的12个月期间。这可能与全年的年度报告数字不一致。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧